Angiotensin-Inhibiting Drugs Do Not Impact Disease Activity in Patients with Rheumatoid Arthritis: A Retrospective Cross-Sectional Study

Objectives: Besides their proven effectivity in decreasing the risk of cardiovascular events, angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II type 1 receptor blockers (ARBs) are likely to possess anti-inflammatory properties as well. This study aims to investigate whether the use...

Descripción completa

Detalles Bibliográficos
Autores principales: Sluijsmans, Dorien M. C. F., Rohrich, Daphne C., Popa, Calin D., van den Bemt, Bart J. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124323/
https://www.ncbi.nlm.nih.gov/pubmed/34063142
http://dx.doi.org/10.3390/jcm10091985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124323/
https://www.ncbi.nlm.nih.gov/pubmed/34063142
http://dx.doi.org/10.3390/jcm10091985

Ejemplares similares